Last reviewed · How we verify

NCT04525690

Improving Inpatient Screening for Hepatitis C

Completed NA Last updated 17 August 2021
What this trial tests

NA trial testing Nudge in Hepatitis C in 7,634 participants. Completed in 10 April 2021.

Timeline
21 September 2020
Primary endpoint
10 April 2021
10 April 2021

Quick facts

Lead sponsorUniversity of Pennsylvania
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposehealth services research
Enrollment7,634
Start date21 September 2020
Primary completion10 April 2021
Estimated completion10 April 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of a Default Order vs an Alert in the Electronic Health Record on Hepatitis C Virus Screening Among Hospitalized Patients: A Stepped-Wedge Randomized Clinical Trial.
    Mehta SJ, Torgersen J, Small DS, Mallozzi CP, et al · · 2022 · cited 18× · PMID 35297973 · DOI 10.1001/jamanetworkopen.2022.2427

Verify or expand the search:

Other trials of Nudge

Trials testing the same drug.

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

Other University of Pennsylvania trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04525690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing